Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors
Robert A Kloner,Gary Comstock,Laurence A Levine,Steven Tiger,Vera J Stecher
Expert Opinion on Pharmacotherapy.2011;12(15)2297
[DOI]
2The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial
Donald T. Weed,Serena Zilio,Isildinha M. Reis,Zoukaa Sargi,Marianne Abouyared,Carmen R. Gomez-Fernandez,Francisco J. Civantos,Carla P. Rodriguez,Paolo Serafini
Frontiers in Immunology.2019;10(15)2297
[DOI]
3Non-Sexual Implications of Phosphodiesterase Type 5 Inhibitors
Taymour Mostafa
Sexual Medicine Reviews.2017;5(2)170
[DOI]
4Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence
Jung Ki Jo,Kwangmo Kim,Sang Eun Lee,Jung Keun Lee,Seok-Soo Byun,Sung Kyu Hong
Annals of Surgical Oncology.2016;23(5)1760
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal